160 related articles for article (PubMed ID: 38441525)
1. Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: An open-label randomized controlled study.
Dani C; Napolitano M; Barone C; Manna A; Nigro G; Scarpelli G; Bonanno E; Gatto S; Cavigioli F; Forcellini C; Petoello E; Beghini R; Ciarcià M; Fusco M; Mosca F; Lavizzari A; Gitto E; Barbuscia L; Betta P; Mattia C; Corvaglia L; Vedovato S; Vento G; Maffei G; Falsaperla R; Lago P; Boni L; Lista G;
Pediatr Pulmonol; 2024 Apr; 59(4):1006-1014. PubMed ID: 38441525
[TBL] [Abstract][Full Text] [Related]
2. Nasal intermittent positive pressure ventilation after surfactant treatment for respiratory distress syndrome in preterm infants <30 weeks' gestation: a randomized, controlled trial.
Ramanathan R; Sekar KC; Rasmussen M; Bhatia J; Soll RF
J Perinatol; 2012 May; 32(5):336-43. PubMed ID: 22301528
[TBL] [Abstract][Full Text] [Related]
3. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
Lemyre B; Deguise MO; Benson P; Kirpalani H; Ekhaguere OA; Davis PG
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD005384. PubMed ID: 37466143
[TBL] [Abstract][Full Text] [Related]
4. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial.
Mishra A; Joshi A; Londhe A; Deshmukh L
Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036
[TBL] [Abstract][Full Text] [Related]
5. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
[TBL] [Abstract][Full Text] [Related]
6. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.
Lemyre B; Laughon M; Bose C; Davis PG
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD005384. PubMed ID: 27976361
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation vs Noninvasive High-Frequency Oscillatory Ventilation as Support After Extubation of Neonates Born Extremely Preterm or With More Severe Respiratory Failure: A Secondary Analysis of a Randomized Clinical Trial.
Zhu X; Li F; Shi Y; Feng Z; De Luca D;
JAMA Netw Open; 2023 Jul; 6(7):e2321644. PubMed ID: 37399009
[TBL] [Abstract][Full Text] [Related]
8. Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure for preterm infants with respiratory distress syndrome: a meta-analysis and up-date.
Li W; Long C; Zhangxue H; Jinning Z; Shifang T; Juan M; Renjun L; Yuan S
Pediatr Pulmonol; 2015 Apr; 50(4):402-9. PubMed ID: 25418007
[TBL] [Abstract][Full Text] [Related]
9. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
[TBL] [Abstract][Full Text] [Related]
10. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
Kaniewska U; Gulczyńska E
Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized, controlled study of NIPPV versus nCPAP in preterm and term infants with respiratory distress syndrome.
Shi Y; Tang S; Zhao J; Shen J
Pediatr Pulmonol; 2014 Jul; 49(7):673-8. PubMed ID: 24039148
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive High-Frequency Oscillatory Ventilation vs Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation as Postextubation Support for Preterm Neonates in China: A Randomized Clinical Trial.
Zhu X; Qi H; Feng Z; Shi Y; De Luca D;
JAMA Pediatr; 2022 Jun; 176(6):551-559. PubMed ID: 35467744
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol.
Zhang H; Li J; Zeng L; Gao Y; Zhao W; Han T; Tong X
Front Pediatr; 2022; 10():968462. PubMed ID: 35967549
[TBL] [Abstract][Full Text] [Related]
14. Nasal Continuous Positive Airway Pressure vs. Nasal Intermittent Positive Pressure Ventilation as Initial Treatment After Birth in Extremely Preterm Infants.
Kostekci YE; Okulu E; Bakirarar B; Kraja E; Erdeve O; Atasay B; Arsan S
Front Pediatr; 2022; 10():870125. PubMed ID: 35547537
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Early Nasal Intermittent Positive Pressure Ventilation and Nasal Continuous Positive Airway Pressure in Preterm Infants with Respiratory Distress Syndrome.
Dursun M; Uslu S; Bulbul A; Celik M; Zubarioglu U; Bas EK
J Trop Pediatr; 2019 Aug; 65(4):352-360. PubMed ID: 30239857
[TBL] [Abstract][Full Text] [Related]
16. Nasal intermittent positive pressure ventilation with or without very early surfactant therapy for the primary treatment of respiratory distress syndrome.
Duman N; Tüzün F; Sever AH; Arslan MK; İşcan B; Dilek M; Kumral A; Ozkan H
J Matern Fetal Neonatal Med; 2016; 29(2):252-7. PubMed ID: 25491882
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three different noninvasive ventilation strategies as initial respiratory support in very low birth weight infants with respiratory distress syndrome: A retrospective study.
Buyuktiryaki M; Okur N; Sari FN; Ozer Bekmez B; Bezirganoglu H; Cakir U; Dizdar EA; Oguz SS
Arch Pediatr; 2020 Aug; 27(6):322-327. PubMed ID: 32651144
[TBL] [Abstract][Full Text] [Related]
18. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity.
Lemyre B; Davis PG; De Paoli AG
Cochrane Database Syst Rev; 2000; (3):CD002272. PubMed ID: 10908544
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Efficacy of Nasal Continuous Positive Airway Pressure and Nasal Intermittent Positive Pressure Ventilation in Early Management of Respiratory Distress Syndrome in Preterm Infants.
Gharehbaghi MM; Hosseini MB; Eivazi G; Yasrebinia S
Oman Med J; 2019 Mar; 34(2):99-104. PubMed ID: 30918602
[TBL] [Abstract][Full Text] [Related]
20. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
Lemyre B; Davis PG; De Paoli AG; Kirpalani H
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003212. PubMed ID: 28146296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
